908 Devices designs and manufactures compact handheld analyzers that integrate mass spectrometry, FTIR, Raman spectroscopy, and machine learning to identify unknown chemicals and hazards at the point of need. Products such as the MX908 for trace detection and the XplorIR for gas and vapor analysis enable rapid field identification of drugs, explosives, and toxic substances. These devices are used by first responders, law enforcement, military, and hazmat personnel to address narcotics threats, chemical safety, and defense requirements without reliance on fixed laboratories.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q1 2025 | 11.8 | — | 43.6 | — |
| Q2 2025 | 13 | — | -13.3 | — |
| Q3 2025 | 14 | — | -15 | — |
| Q4 2025 | 17.4 | — | 4.2 | — |
| Q1 2026 | 13.4 | 13.6% | -12 | -127.4% |
| Q2 2026 | 16.1 | 23.3% | -11.9 | — |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: Neurogene Inc. (NGNE), Monopar Therapeutics Inc. (MNPR), General Catalyst Global Resilience Merger Corp. (GCGR), QVC Group Inc. (QVCG), Gravity Co., Ltd. (GRVY), Kura Sushi USA, Inc. (KRUS)